Metoprolol

Metoprolol Manufacturers

• Cardinal Health
  

  ×

  Metoprolol | Mineralhouse Corporation

  

  ---

  Direction:
  Adults and children over 3 months old
  Step1: Clean and dry the face or the body
  Step2: Spread a proper amount thoroughly to the face or the body
  Children under 3 months old
  Consult your medical professional

  Close
  No Recall

  More Info
• Sagent Pharmaceuticals
  

  ×

  Metoprolol | Sagent Pharmaceuticals

  

  ---

  Myocardial Infarction

  Early Treatment: During the early phase of definite or suspected acute myocardial infarction, initiate treatment with metoprolol as soon as possible after the patient's arrival in the hospital. Such treatment should be initiated in a coronary care or similar unit immediately after the patient's hemodynamic condition has stabilized.

  Begin treatment in this early phase with the intravenous administration of three bolus injections of 5 mg of metoprolol each; give the injections at approximately 2-minute intervals. During the intravenous administration of metoprolol, monitor blood pressure, heart rate, and electrocardiogram.

  In patients who tolerate the full intravenous dose (15 mg), initiate metoprolol tablets, 50 mg every 6 hours, 15 minutes after the last intravenous dose and continue for 48 hours. Thereafter, the maintenance dosage is 100 mg orally twice daily.

  Start patients who appear not to tolerate the full intravenous dose on metoprolol tablets either 25 mg or 50 mg every 6 hours (depending on the degree of intolerance) 15 minutes after the last intravenous dose or as soon as their clinical condition allows. In patients with severe intolerance, discontinue metoprolol (see WARNINGS).

  Special populations

  Pediatric patients: No pediatric studies have been performed. The safety and efficacy of metoprolol in pediatric patients have not been established.

  Renal impairment: No dose adjustment of metoprolol is required in patients with renal impairment.

  Hepatic impairment: Metoprolol blood levels are likely to increase substantially in patients with hepatic impairment. Therefore, metoprolol should be initiated at low doses with cautious gradual dose titration according to clinical response.

  Geriatric patients (>65 years): In general, use a low initial starting dose in elderly patients given their greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

  Method of administration:

  Parenteral administration of metoprolol (vial) should be done in a setting with intensive monitoring.

  Note: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

  Close
  No Recall

  More Info
• Fresenius Kabi Usa, Llc
  

  ×

  Metoprolol | Fresenius Kabi Usa, Llc

  

  ---

  Myocardial Infarction
  

  Early Treatment

  During the early phase of definite or suspected acute myocardial infarction, initiate treatment with metoprolol tartrate as soon as possible after the patient’s arrival in the hospital.  Such treatment should be initiated in a coronary care or similar unit immediately after the patient’s hemodynamic condition has stabilized. 

  Begin treatment in this early phase with the intravenous administration of three bolus injections of 5 mg of metoprolol tartrate injection each; give the injections at approximately 2-minute intervals.  During the intravenous administration of metoprolol tartrate injection, monitor blood pressure, heart rate, and electrocardiogram.

  In patients who tolerate the full intravenous dose (15 mg), initiate metoprolol tartrate tablets, 50 mg every 6 hours, 15 minutes after the last intravenous dose and continued for 48 hours.  Thereafter, the maintenance dosage is 100 mg orally twice daily.

  Start patients who appear not to tolerate the full intravenous on metoprolol tartrate tablets either 25 mg or 50 mg every 6 hours (depending on the degree of intolerance) 15 minutes after the last intravenous dose or as soon as their clinical condition allows.  In patients with severe intolerance, discontinue metoprolol tartrate (see WARNINGS).

  Special Populations
  

  Pediatric Patients

  No pediatric studies have been performed.  The safety and efficacy of metoprolol tartrate in pediatric patients have not been established.

  Renal Impairment

  No dose adjustment of metoprolol tartrate is required in patients with renal impairment.

  Hepatic Impairment

  Metoprolol tartrate blood levels are likely to increase substantially in patients with hepatic impairment.  Therefore, metoprolol tartrate should be initiated at low doses with cautious gradual dose titration according to clinical response.

  Geriatric Patients (>65 years)

  In general, use a low initial starting dose in elderly patients given their greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

  Method of Administration

  Parenteral administration of metoprolol tartrate should be done in a setting with intensive monitoring.

  Note: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

  Myocardial Infarction
  

  Early Treatment

  During the early phase of definite or suspected acute myocardial infarction, initiate treatment with metoprolol tartrate as soon as possible after the patient’s arrival in the hospital.  Such treatment should be initiated in a coronary care or similar unit immediately after the patient’s hemodynamic condition has stabilized. 

  Begin treatment in this early phase with the intravenous administration of three bolus injections of 5 mg of metoprolol tartrate injection each; give the injections at approximately 2-minute intervals.  During the intravenous administration of metoprolol tartrate injection, monitor blood pressure, heart rate, and electrocardiogram.

  In patients who tolerate the full intravenous dose (15 mg), initiate metoprolol tartrate tablets, 50 mg every 6 hours, 15 minutes after the last intravenous dose and continued for 48 hours.  Thereafter, the maintenance dosage is 100 mg orally twice daily.

  Start patients who appear not to tolerate the full intravenous on metoprolol tartrate tablets either 25 mg or 50 mg every 6 hours (depending on the degree of intolerance) 15 minutes after the last intravenous dose or as soon as their clinical condition allows.  In patients with severe intolerance, discontinue metoprolol tartrate (see WARNINGS).

  Close
  No Recall

  More Info
• Claris Lifesciences Inc.
  

  ×

  Metoprolol | Good Sense (geiss, Destin & Dunn, Inc.)

  

  ---

  do not take more than the recommended dose adults and children 12 years and older take 2 caplets with water repeat every 6 hours, as needed do not take more than 6 caplets in 24 hours children under 12 years: consult a doctor

  Close
  No Recall

  More Info